← All trials
NCT04860258
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 22, 2021
- Primary completion
- Sep 21, 2021
- Completion date
- Sep 21, 2021
- First posted
- Apr 26, 2021
- Last posted
- Oct 4, 2021
- Enrollment
- 129
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CureVac AGLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.